Here are Some Higher Beta Stocks

Some higher beta stocks that are at...or very close to being great r/r:

1.

$NEBIUS(NBIS)$: A top 10 position already for me. ARR is at $3B now and I'm modelling ~$70B for 2030.

2.

$Credo Technology Group Holding Ltd(CRDO)$: I want a slightly lower price to add but forecasting ~$10 EPS in FY28 which is 70% CAGR from today which at 35x multiple (0.5x PEG) gives you a $350 stock.

3.

$Bloom Energy Corp(BE)$: Incredible business inflection with operating income +700% and revs +166%.

$NEBIUS(NBIS)$ has cancelled a combustion order to switch to $Bloom Energy Corp(BE)$.

4.

$Cerebras Systems(CBRS)$: Incredible tech and fundamentally different approach to AI compute. ~$190 is where I'd like to see some consolidation.

5.

$Aeva Technologies Inc.(AEVA)$: I think there's a 3x opportunity from ~$18 but just one I'd size accordingly as the CPO/NPO ramp up is quite unknown.

6.

$Amazon.com(AMZN)$: SOTP valuation just makes no sense imo at $2.8T MC.

7.

$Applied Optoelectronics(AAOI)$: Currently trades at 1.6x FY28 forecasted revenue which is one of the lowest out there out of the 2026->2028 ramp up story.

8.

$Invesco Solar ETF(TAN)$: IEA forecasts put solar + wind at ~27% of global electricity generation by 2030. I find some individual solar plays a little risky to pick so $Invesco Solar ETF(TAN)$ is my play here.

9.

$DLocal Limited(DLO)$: Forecasting ~$3.3B in revs by 2030. At 20% NI margins I think a $2 EPS is the forecast which means at 15x EPS (very conservative) we have a 2x from here.

10.

$Tempus AI(TEM)$: Owning the quality data will be the moat for the next 10+ years. Nobody else has unrestricted, identified, multi-modal clinical + molecular data at $Tempus AI(TEM)$'s scale.